Your browser doesn't support javascript.
loading
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2).
Strauss, Victoria Y; Shaw, Rachel; Virdee, Pradeep S; Hurt, Christopher N; Ward, Elizabeth; Tranter, Bethan; Patel, Neel; Bridgewater, John; Parsons, Philip; Radhakrishna, Ganesh; O'Neill, Eric; Sebag-Montefiore, David; Hawkins, Maria; Corrie, Pippa G; Maughan, Timothy; Mukherjee, Somnath.
Afiliação
  • Strauss VY; Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
  • Shaw R; Oncology Clinical Trials Office, University of Oxford, Oxford, UK.
  • Virdee PS; Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
  • Hurt CN; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Ward E; Clinical Trials and Evaluation Unit, Bristol Royal Infirmary, Bristol, UK.
  • Tranter B; Pharmacy Department, Velindre Cancer Centre, Velindre NHS University Trust, Cardiff, UK.
  • Patel N; Department of Radiology, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.
  • Bridgewater J; Department of Oncology, University College London Hospitals, London, UK.
  • Parsons P; Cardiff NCRI RTTQA group, Department of Medical Physics, Velindre Cancer Centre, Cardiff, UK.
  • Radhakrishna G; Oncology Department, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, UK.
  • O'Neill E; Department of Oncology, University of Oxford, CRUK MRC Oxford Institute for Radiation Oncology, Oxford, UK.
  • Sebag-Montefiore D; University of Leeds, Leeds Cancer Centre, St James's University Hospital, Leeds, UK.
  • Hawkins M; Department of Oncology, University of Oxford, CRUK MRC Oxford Institute for Radiation Oncology, Oxford, UK.
  • Corrie PG; Cambridge Cancer Centre, Addenbrooke's Hospital, Cambridge, UK.
  • Maughan T; Department of Oncology, University of Oxford, CRUK MRC Oxford Institute for Radiation Oncology, Oxford, UK.
  • Mukherjee S; Department of Oncology, University of Oxford, CRUK MRC Oxford Institute for Radiation Oncology, Oxford, UK. somnath.mukherjee@oncology.ox.ac.uk.
BMC Cancer ; 19(1): 121, 2019 Feb 04.
Article em En | MEDLINE | ID: mdl-30717707
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Segunda Neoplasia Primária / Quimiorradioterapia / Quimioterapia de Indução Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Segunda Neoplasia Primária / Quimiorradioterapia / Quimioterapia de Indução Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido